scholarly article | Q13442814 |
P50 | author | Daniela Loessner | Q38544906 |
Konstantin I. Momot | Q48149121 | ||
Marietta Landgraf | Q58210451 | ||
Patrina S P Poh | Q85618026 | ||
P2093 | author name string | Ali Shokoohmand | |
Monique C Tourell | |||
Nina P Holzapfel | |||
P2860 | cites work | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
MR elastography derived shear stiffness--a new imaging biomarker for the assessment of early tumor response to chemotherapy. | Q30427432 | ||
Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging | Q30606326 | ||
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors | Q30620964 | ||
Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging | Q30655321 | ||
Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? | Q30678450 | ||
Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy | Q30682911 | ||
Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. | Q30690776 | ||
Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography | Q30764503 | ||
Effect of partial H2O-D2O replacement on the anisotropy of transverse proton spin relaxation in bovine articular cartilage | Q30882129 | ||
Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density. | Q30919446 | ||
Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy | Q30983132 | ||
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response | Q30986317 | ||
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. | Q30992467 | ||
Diffusion MRI in early cancer therapeutic response assessment | Q31037179 | ||
Diffusion-weighted magnetic resonance imaging and its application to cancer | Q31063957 | ||
MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms | Q31096605 | ||
Diffusion-weighted MRI in the body: applications and challenges in oncology | Q31113294 | ||
Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy. | Q31147727 | ||
Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging | Q31975474 | ||
Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response | Q32024887 | ||
Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo | Q33178575 | ||
Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis | Q33260013 | ||
The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle | Q33361929 | ||
Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer | Q33384284 | ||
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy | Q33496147 | ||
Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up | Q34048029 | ||
Predicting and monitoring cancer treatment response with diffusion-weighted MRI. | Q34052992 | ||
The extracellular matrix at a glance | Q34152843 | ||
Cancer of the ovary | Q34375262 | ||
A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread | Q34798735 | ||
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer | Q35017209 | ||
Ovarian cancer: strategies for overcoming resistance to chemotherapy | Q35166813 | ||
Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses | Q35195958 | ||
Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo | Q36134437 | ||
Diagnostic accuracy of diffusion-weighted imaging with conventional MR imaging for differentiating complex solid and cystic ovarian tumors at 1.5T | Q36444552 | ||
Evaluation of primary adnexal masses by 3T MRI: categorization with conventional MR imaging and diffusion-weighted imaging | Q36621438 | ||
Mechanisms of resistance to cisplatin and carboplatin | Q36750435 | ||
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. | Q37073257 | ||
Value of magnetic resonance imaging for the diagnosis of ovarian tumors: a review | Q37284582 | ||
Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study. | Q37593722 | ||
Imaging ovarian cancer and peritoneal metastases--current and emerging techniques | Q37729815 | ||
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). | Q37832624 | ||
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines | Q41607935 | ||
Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors | Q43285053 | ||
Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results | Q47912369 | ||
Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas | Q48276582 | ||
MR elastography of breast cancer: preliminary results | Q48633635 | ||
Real-time elastography for detecting prostate cancer: preliminary experience. | Q50468233 | ||
Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. | Q51865131 | ||
High-resolution tensor MR elastography for breast tumour detection. | Q52077047 | ||
Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. | Q53175270 | ||
Early evaluation of cancer response by a new functional biomarker: apparent diffusion coefficient. | Q53285406 | ||
Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage. | Q53634843 | ||
Temperature-dependent self-diffusion coefficients of water and six selected molecular liquids for calibration in accurate 1H NMR PFG measurements | Q56644968 | ||
Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients | Q56748718 | ||
Quantitative diffusion imaging in implanted human breast tumors | Q73204298 | ||
Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging | Q73912003 | ||
Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension | Q81216356 | ||
Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components | Q82261651 | ||
Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses | Q83947449 | ||
Value of diffusion-weighted imaging for assessing site-specific response of advanced ovarian cancer to neoadjuvant chemotherapy: correlation of apparent diffusion coefficients with epithelial and stromal densities on histology | Q84114621 | ||
Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation | Q87972672 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chemotherapy | Q974135 |
xenograft | Q64148587 | ||
tumour xenograft | Q112042499 | ||
P304 | page(s) | 42905 | |
P577 | publication date | 2017-02-21 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts | |
P478 | volume | 7 |
Q42620668 | A data-driven statistical model that estimates measurement uncertainty improves interpretation of ADC reproducibility: a multi-site study of liver metastases. |
Q59127014 | Clinical translation of [F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer |
Q64054778 | Considering tumour volume for motion corrected DWI of colorectal liver metastases increases sensitivity of ADC to detect treatment-induced changes |
Q91260488 | Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging |
Q90121696 | Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis |
Q55260351 | Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study. |
Q38654867 | The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. |